RSRC1 suppresses gastric cancer cell proliferation and migration by regulating PTEN expression

Yu,Shijun; Gautam,Nishim; Quan,Ming; Gao,Yong

doi:10.3892/mmr.2019.10409

RSRC1 suppresses gastric cancer cell proliferation and migration by regulating PTEN expression

Authors:
- Shijun Yu
- Nishim Gautam
- Ming Quan
- Yong Gao
View Affiliations

Affiliations: Department of Oncology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai 200120, P.R. China
Published online on: June 21, 2019 https://doi.org/10.3892/mmr.2019.10409
Pages: 1747-1753
Copyright: © Yu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Arginine/serine‑rich coiled coil 1 (RSRC1) is a gene which plays a significant role in the constitutive and alternative splicing of mRNA and transcriptional regulation. It has been implicated in various neurological disorders, as well as in cancer. However, its role in gastric cancer (GC) remains unknown. Thus, the present study aimed to investigate the role of RSRC1 in GC. RSRC1 expression in GC tissues was determined by RT‑qPCR and immunohistochemical staining. The effects of RSRC1 on cell proliferation and migration were detected using a Cell Counting Kit‑8 assay, 5‑ethynyl‑2'‑deoxyuridine (EdU) incorporation assay and a Transwell migration assay. Western blot analysis and RT‑qPCR were used to explore the molecular mechanisms of of action of RSRC1 in GC. The results indicated that RSRC1 expression was downregulated in GC tissues compared to paired normal tissues and the reduced expression of RSRC1 was shown to contribute to a poor prognosis of patients with GC. RSRC1 knockdown promoted the proliferation and migration of GC cells. In addition, the knockdown of RSRC1 decreased the expression of phosphatase and tensin homolog deleted on chromosome 10 (PTEN), a potent tumor suppressor gene controlling cellular growth and viability. On the whole, the findings of the present study indicate that RSRC1 functions as a tumor suppressor gene in GC and that it may exert its effects by regulating PTEN expression.

View Figures

View References

1	Carcas LP: Gastric cancer review. J Carcinog. 13:142014. View Article : Google Scholar : PubMed/NCBI
2	Watson GL, Goff C and Shi P: Pohlmann: Molecular profiling of gastric cancer. My Cancer Genome. Mar 16–2018.
3	Mihmanli M, Ilhan E, Idiz UO, Alemdar A and Demir U: Recent developments and innovations in gastric cancer. World J Gastroenterol. 22:4307–4320. 2016. View Article : Google Scholar : PubMed/NCBI
4	McFarlane M, Brettschneider J, Gelsthorpe A, James S, Snead D, Gopalakrishnan K, Mehenna H, Jankowski J, Arasaradnam R and Nwokolo C: An assessment of candidate genes to assist prognosis in gastric cancer. J Gastrointest Oncol. 9:303–310. 2018. View Article : Google Scholar : PubMed/NCBI
5	Yusefi AR, Bagheri Lankarani K, Bastani P, Radinmanesh M and Kavosi Z: Risk factors for gastric cancer: A systematic review. Asian Pac J Cancer Prev. 19:591–603. 2018.PubMed/NCBI
6	McDaniel LD, Conkrite KL, Chang X, Capasso M, Vaksman Z, Oldridge DA, Zachariou A, Horn M, Diamond M, Hou C, et al: Common variants upstream of MLF1 at 3q25 and within CPZ at 4p16 associated with neuroblastoma. PLoS Genet. 13:e10067872017. View Article : Google Scholar : PubMed/NCBI
7	Perez Y, Menascu S, Cohen I, Kadir R, Basha O, Shorer Z, Romi H, Meiri G, Rabinski T, Ofir R, et al: RSRC1 mutation affects intellect and behaviour through aberrant splicing and transcription, downregulating IGFBP3. Brain. 141:961–970. 2018. View Article : Google Scholar : PubMed/NCBI
8	Cazalla D, Newton K and Caceres JF: A novel SR-related protein is required for the second step of Pre-mRNA splicing. Mol Cell Biol. 25:2969–2980. 2005. View Article : Google Scholar : PubMed/NCBI
9	Teplyuk NM, Uhlmann EJ, Gabriely G, Volfovsky N, Wang Y, Teng J, Karmali P, Marcusson E, Peter M, Mohan A, et al: Therapeutic potential of targeting microRNA-10b in established intracranial glioblastoma: First steps toward the clinic. EMBO Mol Med. 8:268–287. 2016. View Article : Google Scholar : PubMed/NCBI
10	Pflueger D, Terry S, Sboner A, Habegger L, Esgueva R, Lin PC, Svensson MA, Kitabayashi N, Moss BJ, MacDonald TY, et al: Discovery of non-ETS gene fusions in human prostate cancer using next-generation RNA sequencing. Genome Res. 21:56–67. 2011. View Article : Google Scholar : PubMed/NCBI
11	Kurehara H, Ishiguro H, Kimura M, Mitsui A, Ando T, Sugito N, Mori R, Takashima N, Ogawa R, Fujii Y and Kuwabara Y: A novel gene, RSRC2, inhibits cell proliferation and affects survival in esophageal cancer patients. Int J Oncol. 30:421–428. 2007.PubMed/NCBI
12	Wolf M, Korja M, Karhu R, Edgren H, Kilpinen S, Ojala K, Mousses S, Kallioniemi A and Haapasalo H: Array-based gene expression, CGH and tissue data defines a 12q24 gain in neuroblastic tumors with prognostic implication. BMC Cancer. 10:1812010. View Article : Google Scholar : PubMed/NCBI
13	Hopkins BD, Hodakoski C, Barrows D, Mense SM and Parsons RE: PTEN function: The long and the short of it. Trends Biochem Sci. 39:183–190. 2014. View Article : Google Scholar : PubMed/NCBI
14	Yao H, Su S, Xia D, Wang M, Li Z, Chen W, Ren L and Xu L: F-box and leucine-rich repeat protein 5 promotes colon cancer progression by modulating PTEN/PI3K/AKT signaling pathway. Biomed Pharmacother. 107:1712–1719. 2018. View Article : Google Scholar : PubMed/NCBI
15	Naderali E, Khaki AA, Rad JS, Ali-Hemmati A, Rahmati M and Charoudeh HN: Regulation and modulation of PTEN activity. Mol Biol Rep. 45:2869–2881. 2018. View Article : Google Scholar : PubMed/NCBI
16	Lu R, Zhao G, Yang Y, Jiang Z, Cai J, Zhang Z and Hu H: Long noncoding RNA HOTAIRM1 inhibits cell progression by regulating miR-17-5p/PTEN axis in gastric cancer. J Cell Biochem. 120:4952–4965. 2019. View Article : Google Scholar : PubMed/NCBI
17	Lee YR, Chen M and Pandolfi PP: The functions and regulation of the PTEN tumour suppressor: New modes and prospects. Nat Rev Mol Cell Biol. 19:547–562. 2018. View Article : Google Scholar : PubMed/NCBI
18	Zhang LL, Liu J, Lei S, Zhang J, Zhou W and Yu HG: PTEN inhibits the invasion and metastasis of gastric cancer via downregulation of FAK expression. Cell Signal. 26:1011–1020. 2014. View Article : Google Scholar : PubMed/NCBI
19	Xu W, Yang Z, Xie C, Zhu Y, Shu X, Zhang Z, Li N, Chai N, Zhang S, Wu K, et al: PTEN lipid phosphatase inactivation links the hippo and PI3K/Akt pathways to induce gastric tumorigenesis. J Exp Clin Cancer Res. 37:1982018. View Article : Google Scholar : PubMed/NCBI
20	Ding K, Wu Z, Wang N, Wang X, Wang Y, Qian P, Meng G and Tan S: MiR-26a performs converse roles in proliferation and metastasis of different gastric cancer cells via regulating of PTEN expression. Pathol Res Pract. 213:467–475. 2017. View Article : Google Scholar : PubMed/NCBI
21	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
22	Chen L, Li W, Qiu W, Ren W, Li Q, Han B, Zhou L, Cheng L, Zhang H and Ye Q: RSRC1 SUMOylation enhances SUMOylation and inhibits transcriptional activity of estrogen receptor β. FEBS Lett. 589:1476–1484. 2015. View Article : Google Scholar : PubMed/NCBI
23	Tang J, Liu W, Zhu J, Zhang J, Wang FH, Liang JH, Zeng JH, Wang H, Xia H and He J: RSRC1 and CPZ gene polymorphisms with neuroblastoma susceptibility in Chinese children. Gene. 662:83–87. 2018. View Article : Google Scholar : PubMed/NCBI
24	Davidson L, Maccario H, Perera NM, Yang X, Spinelli L, Tibarewal P, Glancy B, Gray A, Weijer CJ, Downes CP and Leslie NR: Suppression of cellular proliferation and invasion by the concerted lipid and protein phosphatase activities of PTEN. Oncogene. 29:687–697. 2010. View Article : Google Scholar : PubMed/NCBI
25	Ko BS, Chang TC, Chen CH, Liu CC, Kuo CC, Hsu C, Shen YC, Shen TL, Golubovskaya VM, Chang CC, et al: Bortezomib suppresses focal adhesion kinase expression via interrupting nuclear factor-kappa B. Life Sci. 86:199–206. 2010. View Article : Google Scholar : PubMed/NCBI
26	Wang X and Jiang X: PTEN: A default gate-keeping tumor suppressor with a versatile tail. Cell Res. 18:807–816. 2008. View Article : Google Scholar : PubMed/NCBI
27	Ma J, Guo X, Zhang J, Wu D, Hu X, Li J, Lan Q, Liu Y and Dong W: PTEN gene induces cell invasion and migration via regulating AKT/GSK-3β/β-catenin signaling pathway in human gastric cancer. Dig Dis Sci. 62:3415–3425. 2017. View Article : Google Scholar : PubMed/NCBI